Modality-aware discriminative fusion network for integrated analysis of brain imaging genomics

• Main Authors: SHENG, Xiaoqi, CAI, Hongmin, NIE, Yongwei, HE, Shengfeng, CHEUNG, Yiu-Ming, CHEN, Jiazhou
• Format: text
• Language: English
• Published: Institutional Knowledge at Singapore Management University 2024
• Subjects: Brain imaging genomics; early diagnosis; mild cognitive impairment (MCI); multimodal fusion; Artificial Intelligence and Robotics; OS and Networks
• Online Access: https://ink.library.smu.edu.sg/sis_research/9800
• Institution: Singapore Management University

Mild cognitive impairment (MCI) represents an early stage of Alzheimer's disease (AD), characterized by subtle clinical symptoms that pose challenges for accurate diagnosis. The quest for the identification of MCI individuals has highlighted the importance of comprehending the underlying mechanisms of disease causation. Integrated analysis of brain imaging and genomics offers a promising avenue for predicting MCI risk before clinical symptom onset. However, most existing methods face challenges in: 1) mining the brain network-specific topological structure and addressing the single nucleotide polymorphisms (SNPs)-related noise contamination and 2) extracting the discriminative properties of brain imaging genomics, resulting in limited accuracy for MCI diagnosis. To this end, a modality-aware discriminative fusion network (MA-DFN) is proposed to integrate the complementary information from brain imaging genomics to diagnose MCI. Specifically, we first design two modality-specific feature extraction modules: the graph convolutional network with edge-augmented self-attention module (GCN-EASA) and the deep adversarial denoising autoencoder module (DAD-AE), to capture the topological structure of brain networks and the intrinsic distribution of SNPs. Subsequently, a discriminative-enhanced fusion network with correlation regularization module (DFN-CorrReg) is employed to enhance inter-modal consistency and between-class discrimination in brain imaging and genomics. Compared to other state-of-the-art approaches, MA-DFN not only exhibits superior performance in stratifying cognitive normal (CN) and MCI individuals but also identifies disease-related brain regions and risk SNPs locus, which hold potential as putative biomarkers for MCI diagnosis.